Sean F Sullivan

US Patent:

20120041381, Feb 16, 2012

Filed:

Aug 8, 2011

Appl. No.:

13/205466

Inventors:

Abhijitsinh Raj - Parsippany NJ, US
Sean Sullivan - Ridgewood NJ, US
Robert Banik - Long Valley NJ, US
James S. Bates - Sparta NJ, US
Cole Constantineau - Cambridge MA, US
Ryan Schoonmaker - San Marcos CA, US
Michel Bruehwiler - Newton MA, US
Joshua D. Horvath - Sparta NJ, US
Doug Lawrence - Kinnelon NJ, US

Assignee:

BECTON, DICKINSON AND COMPANY - Franklin Lakes NJ

International Classification:

A61M 5/32
B23P 17/04

US Classification:

604192, 29428

Abstract:

A pen needle includes a hub having a first opening at a first end and a second opening at a second end. A needle is connected to the hub and extends through the first opening at the first end. Access to the needle through the second opening is prevented by a sterility barrier, which has a movable portion that is moved along a longitudinal axis of the needle to provide access to the needle. A storage container includes a housing having a plurality of cavities to receive a plurality of pen needles. A cover is rotatably connected to the housing and is rotated such that an access portion thereof is aligned with one of the cavities, thereby providing access to the pen needle in the cavity.

US Patent:

20230043046, Feb 9, 2023

Filed:

Oct 30, 2020

Appl. No.:

17/773416

Inventors:

- Philadelphia PA, US
Sean Sullivan - Milltown NJ, US
Hilary Gray - Philadelphia PA, US

Assignee:

Amicus Therapeutics, Inc. - Philadelphia PA

International Classification:

A61K 48/00
A61P 25/28
C12N 9/12
C12N 15/86

Abstract:

Compositions for CDKL5 gene therapy are provided, as well as recombinant CDKL5 proteins. Such CDKL5 gene therapy compositions and/or recombinant CDKL5 proteins may incorporate cell-penetrating polypeptides and/or leader signal polypeptides. Also provided are methods of producing such gene therapy compositions and recombinant CDKL5 proteins, as well as pharmaceutical compositions, methods of treatment, and uses of the gene therapy compositions and recombinant CDKL5 proteins.

US Patent:

20210247881, Aug 12, 2021

Filed:

Feb 6, 2020

Appl. No.:

16/783921

Inventors:

- Morristown NJ, US
Sean SULLIVAN - Verona NJ, US
Patrick SULLIVAN - Morristown NJ, US
Kevin SULLIVAN - Chatham Township NJ, US
James PERHACS - Long Valley NJ, US
James HOOKS - Fort Mill SC, US
Julie GALBRAITH - Highland Lakes NJ, US
James SULLIVAN - New Rochelle NY, US

International Classification:

G06F 3/0484
G06F 16/23
G06Q 10/10
G06Q 30/00
G06Q 10/06
G06F 3/0482
H04L 12/24

Abstract:

Bi-directional communication, through a computing system, may be used to maintain and monitor regulatory compliance. Employees of a firm may be prompted to provide information, which may be communicated to the computing system and stored in one or more databases. An internal auditor may be provided with a user interface that permits the initiation of audits, viewing of information reported, and/or the opportunity to provide findings and/or comments based on the information reported. The information reported may be provided to the auditor in the form of predetermined types of reports, based on the information reported.

US Patent:

20200331687, Oct 22, 2020

Filed:

Jul 8, 2020

Appl. No.:

16/923794

Inventors:

- Franklin Lakes NJ, US
Deirdre COLLINS - New York NY, US
Charles G. HWANG - Wellesley MA, US
Paul UPHAM - Jersey City NJ, US
Sean SULLIVAN - Jersey City NJ, US
Ed LANGILL - Oakville, CA

Assignee:

Becton, Dickinson and Company - Franklin Lakes NJ

International Classification:

B65D 83/02
A61M 5/00
A61M 5/32
A61B 17/34
A61B 50/20

Abstract:

A pen needle assembly, comprising an outer cover having an open end, a lid removably connected to the open end of the outer cover, a pen needle disposed in the outer cover, and connecting members disposed on opposite sides of the outer cover. Also disclosed is a pen needle assembly, comprising an outer cover having an open end, a lid removably connected to the open end of the outer cover, a pen needle disposed in the outer cover, and connecting members disposed on opposite sides of the outer cover, wherein a plurality of pen needle assemblies are connected adjacent to each other via the connecting members.

US Patent:

20170233168, Aug 17, 2017

Filed:

May 2, 2017

Appl. No.:

15/584526

Inventors:

- Franklin Lakes NJ, US
Deirdre COLLINS - New York NY, US
Charles G. HWANG - Wellesley MA, US
Paul UPHAM - Jersey City NJ, US
Sean Sullivan - Jersey City NJ, US
Ed LANGILL - Oakville, CA

Assignee:

Becton, Dickinson and Company - Franklin Lakes NJ

International Classification:

B65D 83/02
A61M 5/32
A61M 5/00

Abstract:

A pen needle assembly, comprising an outer cover having an open end, a lid removably connected to the open end of the outer cover, a pen needle disposed in the outer cover, and connecting members disposed on opposite sides of the outer cover. Also disclosed is a pen needle assembly, comprising an outer cover having an open end, a lid removably connected to the open end of the outer cover, a pen needle disposed in the outer cover, and connecting members disposed on opposite sides of the outer cover, wherein a plurality of pen needle assemblies are connected adjacent to each other via the connecting members.

US Patent:

20170028141, Feb 2, 2017

Filed:

Dec 3, 2014

Appl. No.:

15/100032

Inventors:

- Franklin Lakes NJ, US
Robert E. WEST - Basking Ridge NJ, US
Sudarsan SRINIVASAN - Hawthorne NJ, US
Michael A. DIBIASI - West Milford NJ, US
Amit LIMAYE - Wayne NJ, US
Brendon HILL - Haworth NJ, US
Sean SULLIVAN - Ridgewood NJ, US

International Classification:

A61M 5/42
A61M 5/00
A61M 5/31
G09B 23/28

Abstract:

Systems and methods encourage users to rotate injection sites and avoid lipodystrophy. Sleeves and/or lost-tooth gear dials and/or microswitches in or on injection pens or their caps, on vials, and on other portable devices manually adjust an indicator before or after an injection to show a current or next injection site in accordance with a site rotation plan. Injected medicine packaging and related printed indicia encourage site rotation. Optical devices employing optical mouse or projection technology help locate and/or distribute injection sites within a body area. A mobile phone app tracks injections and locations to select next injection site, and can use imaging to locate a target injection site and optionally diagnose lipodystrophic conditions and record them. Tactile and print media educational tools are presented to help users palpate and identify lipos in body areas having injection sites.

US Patent:

20150157807, Jun 11, 2015

Filed:

Dec 9, 2014

Appl. No.:

14/564634

Inventors:

- Franklin Lakes NJ, US
Amit Limaye - Wayne NJ, US
Michael DiBiasi - West Milford NJ, US
Sean Sullivan - Ridgewood NJ, US

International Classification:

A61M 5/32

Abstract:

The subject invention provides a safety pen needle assembly which includes: a hub; a needle carrier; a needle fixed to the needle carrier; a shield; and, a first engageable locking arrangement for fixing the shield to the needle carrier. Upon a predetermined extent of distal movement of the shield relative to the hub, the first locking arrangement is engaged such that the shield becomes fixed to the needle carrier. Upon further distal movement of the shield relative to the hub beyond the predetermined extent of distal movement, the shield and the needle carrier move in concert together relative to the hub causing a proximal end of the needle to move distally relative to the hub to a retracted state. Advantageously, the subject invention provides a reliable, low-cost safety pen needle assembly which does not require a spring or other biasing element.

US Patent:

20150003498, Jan 1, 2015

Filed:

Jan 24, 2013

Appl. No.:

14/373468

Inventors:

- Norcross GA, US
Sean Sullivan - Keansburg NJ, US
William J. Strachan - Hillsborough NJ, US

International Classification:

G02B 6/255
G01K 11/32

US Classification:

374161

Abstract:

The disclosed embodiments show a fused fiber combiner with sensors that are strategically located at various locations, thereby permitting performance monitoring of the fused fiber combiner. Additionally, the disclosed embodiments show various processes for determining causes of any performance degradations.